- Modern. The vaccine enters the final phase of clinical trials this month.
- Breaking news - all information about the coronavirus
The US pharmaceutical company Moderna begins phase 3 of the trial of its experimental vaccine against coronavirus disease tomorrow Monday and has successfully doubled government funding for the drug to $ 955 million, it announced on Sunday.
In a statement, Moderna said that it has modified its contract with the BARDA (Biomedical Advanced Research and Development Authority) to expand the initial amount that it was going to allocate to the development of the mRNA-1273 vaccine, which enters into $ 472 million. its advanced stage.
"After discussions with the US Food and Drug Administration and consultations with Operation" Warp Speed "in recent months, the company has decided to run a significantly larger third phase of the clinical trial , leaving a gap in funding for BARDA to be closed thanks to this contract modification, "he said.
According to the criteria of The Trust Project
Know more- Vaccines
- Coronavirus
- Covid 19
ResearchCovid-19 vaccine from the modern pharmaceutical company enters the final phase of clinical trials this month
Covid-19 Health Chemistry Expert: "We are about to have inhibitors against SARS-CoV-2"
ItalyHow long to wait for the Oxford vaccine?
See links of interest
- News
- Translator
- Programming
- Calendar
- Horoscope
- Classification
- Films
- Cut notes
- Themes
- Live: Moto3 Andalusian GP
- Live: Moto2 Andalusian GP
- Live: MotoGP Andalusian GP